Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1.308
1.256 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1.136,37 |
-0,7%
|
$1,07 T |
|
|
|
Johnson & Johnson
JNJ
|
$238,49 |
+0,6%
|
$574,10 B |
|
|
|
Roche Holding AG
ROG
|
CHf324,9 |
+4,1%
|
$329,48 B |
|
|
|
Merck & Co Inc
MRK
|
$119,09 |
-0,4%
|
$294,13 B |
|
|
|
Novartis AG
NOVN
|
CHf119,04 |
+0,6%
|
$284,64 B |
|
|
|
AstraZeneca PLC
AZN
|
GBX13.464 |
-1,2%
|
$279,40 B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$43,5 |
-7,7%
|
$227,99 B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr283,1 |
+5%
|
$193,91 B |
|
|
|
Pfizer Inc
PFE
|
$25,6 |
-0,4%
|
$145,91 B |
1.251 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita
